Many people delayed elective procedures at the height of the pandemic. BTIG's Thibault notes analysts expect Inari Medical to report greater than 20% sales growth for 2024. Importantly ...

“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” Inari had been working with advisers to ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Inari is poised to enhance Stryker's footprint ... patients and will accelerate Stryker’s impact in endovascular procedures.” The transaction, which has been unanimously approved by both ...